Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
-
▾0.00 (0.00%)
Last trade: 20/12, 6:50PM
Market cap
-
Market closed
Talk to Scigen Limited Chess Depositary Interests 1:1 directly.
Sign up to their Investor Hub for direct access to the Scigen Limited Chess Depositary Interests 1:1 team, ask them questions, and see personal updates.
Scigen Limited Chess Depositary Interests 1:1 has been removed from the Australian Securities Exchange official list as of 28/08/2018
Investor Presentations
Principal Activity
SciGen Limited (SIE) is a biopharmaceutical company engaged in co-developing and marketing genetically engineered biopharmaceutical products for human healthcare. SIE focuses in the areas of endocrinology, paediatrics, neurology and oncology care. SIE's portfolio consists of biosimilar products such as rhuman growth hormone, rhuman insulin and rhuman Granulocyte Colony Stimulating Factor (GCSF). SIE is a Singapore-based company, with representatives in Asia Pacific region. Former Names --
Address
1/13B Narabang Way, Belrose NSW 2085, Australia
Website
News
Announcements
Filter
| Announcement | T+2 Movement | Date |
|---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
-
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
| Company | Market Cap | ||
|---|---|---|---|
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.
Support
Live Chat
Markets
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.